STAT3 Polymorphism Associates With mTOR Inhibitor-Induced Interstitial Lung Disease in Patients With Renal Cell Carcinoma

We evaluated the association of signal transducer and activator of transcription 3 (STAT3) polymorphisms with the incidence of mammalian target of rapamycin (mTOR) inhibitor-induced interstitial lung disease (ILD) in patients with renal cell carcinoma (RCC). We also used lung-derived cell lines to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Kazuhiro, Ioroi, Takeshi, Shinomiya, Kazuaki, Yoshida, Ayaka, Harada, Kenichi, Fujisawa, Masato, Omura, Tomohiro, Ikemi, Yasuaki, Nakagawa, Shunsaku, Yonezawa, Atsushi, Ogawa, Osamu, Matsubara, Kazuo, Iwamoto, Takuya, Nishikawa, Kohei, Hayashi, Sayaka, Tohara, Daichi, Murakami, Yoji, Motoshima, Takanobu, Jono, Hirofumi, Yano, Ikuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110706/
https://www.ncbi.nlm.nih.gov/pubmed/35016744
http://dx.doi.org/10.3727/096504022X16418911579334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110706/
https://www.ncbi.nlm.nih.gov/pubmed/35016744
http://dx.doi.org/10.3727/096504022X16418911579334

Ejemplares similares